Over 60 global pharmaceutical companies, large and small, rely on Abveris to develop therapeutic antibody candidates.
Our Boston-based team of discovery scientists is composed of experienced biotherapeutic drug discovery scientists with a passion for novel antibody discovery. We use advanced immunization techniques, engineered in vivo systems, optimized antibody capture methods, robust high-throughput screening technologies, and diverse ancillary capabilities to deliver excellent therapeutic leads with critical timelines in mind.
We like to meet in person with our Boston clients. We can setup a Zoom to connect if you're further away.